Stay updated on Oral Upadacitinib in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Oral Upadacitinib in Atopic Dermatitis Clinical Trial page.

Latest updates to the Oral Upadacitinib in Atopic Dermatitis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdministrative site updates were made: the page shows Revision: v3.4.2 and the operating-status notice about government funding lapse was removed, along with the prior Revision: v3.4.1 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedThe addition includes a site-wide notice about a lapse in government funding and NIH Clinical Center status, plus a version update from 3.4.0 to 3.4.1; these do not affect the study data or details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedAdded a glossary display and small text updates, including a capitalization change in the QC label ('Last Update Submitted that Met QC Criteria') and a revision/version update to v3.4.0 (replacing v3.3.4).SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 added and v3.3.3 removed. There are no visible changes to study details or the page layout.SummaryDifference0.1%

- Check64 days agoChange DetectedFooter updates: added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check85 days agoChange DetectedA new revision label 'Revision: v3.3.2' was added and the previous 'Revision: v3.3.1' label was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Oral Upadacitinib in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Upadacitinib in Atopic Dermatitis Clinical Trial page.